Impact of TP53 functional mutation type on clinical outcomes of advanced breast cancer patients

被引：0
|
作者：
Stjepanovic, N. [1 ]
Garg, S. [1 ]
Berman, H. [1 ]
Warr, D. [1 ]
Amir, E. [1 ]
Cescon, D. [1 ]
Elser, C. [1 ]
Wang, L. [1 ]
Kamel-Reid, S. [1 ]
Siu, L. [1 ]
Bedard, P. L. [1 ]
Stockley, T. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P2-05-19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-05-19
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The R337H mutation in TP53 and breast cancer in Brazil
    Magda CB Gomes
    Joanne Kotsopoulos
    Gutemberg Leão de Almeida
    Mauricio M Costa
    Roberto Vieira
    Firmino de AG Filho
    Marcos B Pitombo
    Paulo Roberto F Leal
    Robert Royer
    Phil Zhang
    Steven A Narod
    Hereditary Cancer in Clinical Practice, 10
  • [42] The R337H mutation in TP53 and breast cancer in Brazil
    Gomes, Magda C. B.
    Kotsopoulos, Joanne
    de Almeida, Gutemberg Leao
    Costa, Mauricio M.
    Vieira, Roberto
    Filho, Firmino de A. G.
    Pitombo, Marcos B.
    Leal, Paulo Roberto F.
    Royer, Robert
    Zhang, Phil
    Narod, Steven A.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2012, 10
  • [43] TP53 mutation hits energy metabolism and increases glycolysis in breast cancer
    Harami-Papp, Hajnalka
    Pongor, Lorinc S.
    Munkacsy, Gyongyi
    Horvath, Gergo
    Nagy, Adam M.
    Ambrus, Attila
    Hauser, Peter
    Szabo, Andras
    Tretter, Laszlo
    Gyorffy, Balazs
    ONCOTARGET, 2016, 7 (41) : 67183 - 67195
  • [44] Recurrent TP53 missense mutation in cancer patients of Arab descent
    Zick, Aviad
    Kadouri, Luna
    Cohen, Sherri
    Frohlinger, Michael
    Hamburger, Tamar
    Zvi, Naama
    Plaser, Morasha
    Avital, Eilat
    Breuier, Shani
    Elian, Firase
    Salah, Azzam
    Goldberg, Yael
    Peretz, Tamar
    FAMILIAL CANCER, 2017, 16 (02) : 295 - 301
  • [45] Recurrent TP53 missense mutation in cancer patients of Arab descent
    Aviad Zick
    Luna Kadouri
    Sherri Cohen
    Michael Frohlinger
    Tamar Hamburger
    Naama Zvi
    Morasha Plaser
    Eilat Avital
    Shani Breuier
    Firase Elian
    Azzam Salah
    Yael Goldberg
    Tamar Peretz
    Familial Cancer, 2017, 16 : 295 - 301
  • [46] Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
    Barekati, Zeinab
    Radpour, Ramin
    Kohler, Corina
    Zhang, Bei
    Toniolo, Paolo
    Lenner, Per
    Lv, Qing
    Zheng, Hong
    Zhong, Xiao Yan
    HUMAN MOLECULAR GENETICS, 2010, 19 (15) : 2936 - 2946
  • [47] TP53 Mutations in Breast and Ovarian Cancer
    Silwal-Pandit, Laxmi
    Langerod, Anita
    Borresen-Dale, Anne-Lise
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (01):
  • [48] Characteristics and survival of patients with advanced cancer and TP53 mutations in phase I clinical trials
    Said, Rabih
    Ye, Yang
    Hong, David S.
    Janku, Filip
    Fu, Siqing
    Naing, Aung
    Wheler, Jennifer J.
    Kurzrock, Razelle
    Thomas, Christoforos
    Palmer, Gary A.
    Hess, Kenneth R.
    Wolff, Robert A.
    Tsimberidou, Apostolia Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients
    Siraj, Abdul Khalid
    Masoodi, Tariq
    Bu, Rong
    Parvathareddy, Sandeep Kumar
    Iqbal, Kaleem
    Azam, Saud
    Al-Rasheed, Maha
    Ajarim, Dahish
    Tulbah, Asma
    Al-Dayel, Fouad
    Al-Kuraya, Khawla Sami
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2021, 19 (01)
  • [50] Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors
    Aceto, Gitana Maria
    Awadelkarim, Khalid Dafaallah
    Di Nicola, Marta
    Moscatello, Carmelo
    Pantalone, Mattia Russel
    Verginelli, Fabio
    Elwali, Nasr Eldin
    Mariani-Costantini, Renato
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (02) : 479 - 485
12345